WithdrawnNot Applicable

COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

Stopped: Covid pandemic prohibited us from completing study-related activities.

United States0Started 2020-08-13

Plain-language summary

This research study will evaluate the association of Androgen Receptor (AR) gene expression and COVID-19 disease severity and mortality. The research procedure involves collection of a single saliva sample which will be mailed to the participants by the study team. This saliva will be used in a COVID-19 Androgen Sensitivity Test (CoVAST) which will detect AR gene expression. Eligible participants are males, at least 18 years or older, and have tested positive for COVID-19.

Who can participate

Age range18 Years – 90 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male over the age of 18 * Laboratory confirmed SARS-CoV-2 infection * Able to give verbal informed consent Exclusion Criteria: * Unable to give informed consent * Diagnosed with an additional respiratory co-infection * XXY males

What they're measuring

Number of patients deceased

Timeframe: 28 days

Trial details

NCT IDNCT04530500

SponsorUniversity of California, Irvine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-01

View on ClinicalTrials.gov More Covid19 trials